News

Elon Musk says Neuralink's Brain-Chip Interface Blindsight implant will undergo first clinical trial in 2026 in UAE.
From where we were at the beginning, it is massive improvements, and the more people that join the study, the better it’s going to get.” ...
Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.
With AlphaFold and machine learning in the mix, we’re entering an era of precision exploration, where the next breakthrough ...
Quantum computing has been lurking in the background for years. Discover 5 cutting-edge science sectors like CRISPR and ...
Levitz, who runs a lab that is working on a vaccine for another type of fungus, said the new study makes him feel optimistic, as it makes progress towards a human vaccine that “would save as ...
The modified T cells will be multiplied in a lab before being re-introduced into the blood of each trial participant. The PD-1 checkpoint pathway has attracted attention from various ...
Internet Is EvolvingA Glimpse at 2016-2036 Tony Antonelli Paving the Way for Human Exploration of Deep Space Adam Steltzner: NASAs Mars 2020 Missionand Beyond Parker Abercrombie and Alexander ...
The human subjects committees of the Harvard School of Public Health, the WHO, and each participating hospital approved the study and waived the requirement for written informed consent from patients.
A US federal judge for the District Court of Massachusetts on Friday temporarily blocked President Donald Trump’s administration from banning Harvard College’s enrollment of international students.
Although there is empirical evidence for a given TLR as a good target for cancer therapy, a compelling rationale is often lacking in human clinical trials. Many cancer patients are ...
قالت رئيسة المنظمة العالمية لصحة الحيوان إيمانويل سوبيران إن تطعيم الحيوانات على نطاق أوسع يمكن أن يساعد ...